Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles
Tóm tắt
Từ khóa
Tài liệu tham khảo
Al Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod17,874–885.
Bourgain C and Devroey P (2003) The endometrium in stimulated cycles for IVF. Hum Reprod Update9,515–522.
Casan EM , Raga F and Polan ML (1999) GnRH mRNA and protein expression in human preimplantation embryos. Mol Hum Reprod5,234–239.
Develioglu OH , Hsiu JG, Nikas G, Toner JP, Oehninger S and Jones HW Jr (1999) Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril71,1040–1047.
Devroey P , Abyholm T, Diedrich K, de Jong D, Hillensjo T, Hedon B, Itskovitz-Eldor J, Kahn J, Naether O, Olivennes F et al (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon™). Hum Reprod13,3023–3031.
Friedler S , Schenker JG, Herman A and Lewin A (1996) The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update2,323–335.
Garcia E , Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E and Perrot-Applanat M (1988) Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab67,80–87.
Ghazeeri GS , Vongprachanh P and Kutteh WH (2000) The predictive value of five different urinary LH kits in detecting the LH surge in regularly menstruating women. Int J Fertil Women’s Med45,321–326.
Gonen Y and Casper RF (1990) Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fertil Embryo Transfer7,146–152.
Hendrickson MR and Kempson RL (1994) The Uterine Corpus. In Sternberg SS, Antonioli DA, Mills SE, Carter D and Oberman HA (eds) Diagnostic Surgical Pathology. 2nd edn, Lippincott–Raven, Philadelphia, pp 2091–2193.
Horcajadas JA , Riesewijk A, Polman J, van Os R, Mosselman S, Pellicer A and Simón C (2005) Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod11,195–205.
Kol S , Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B and Itskovitz-Eldor J (1999) High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles. Hum Reprod14,2242–2244.
Kolb BA and Paulson RJ (1997) The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol176,1262–1267.
Kolibianakis E , Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A and Devroey P (2002) Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril78,1025–1029.
Kolibianakis EM , Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19, 2490–2496.
Leibovitz Z , Grinin V, Rabia R, Degani S, Shapiro I, Tal J, Eibschitz I, Harari O, Paltieli Y, Aharoni A et al (1999) Assessment of endometrial receptivity for gestation in patients undergoing in vitro fertilization, using endometrial thickness and the endometrium–myometrium relative echogenicity coefficient. Ultrasound Obstet Gynecol14,194–199.
Merviel P , Antoine JM, Mathieu E, Millot F, Mandelbaum J and Uzan S (2004) Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization–embryo transfer. Fertil Steril82,119–125.
Navot D , Scott RT, Droesch K, Veeck LL, Liu HC and Rosenwaks Z (1991) The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril55,114–118.
Nikas G (1999) Pinopodes as markers of endometrial receptivity in clinical practice. Hum Reprod14(Suppl 2),99–106.
Nikas G , Develioglu OH, Toner JP and Jones HW Jr (1999) Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles. Hum Reprod14,787–792.
Out HJ and Mannaerts BM (2002) The gonadotrophin-releasing hormone antagonist ganirelix–history and introductory data. Hum Fertil (Camb)5,G5–10.
Raga F , Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F and Polan ML (1999) The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology140,3705–3712.
Riesewijk A , Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, Mosselman S and Simon C (2003) Gene expression profiling of human endometrial receptivity on days LH +2 versus LH +7 by microarray technology. Mol Hum Reprod9,253–264.
Sharara FI , Lim J and McClamrock HD (1999) Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet16,523–528.
Tamaya T , Murakami T and Okada H (1986) Concentrations of steroid receptors in normal human endometrium in relation to the day of the menstrual cycle. Acta Obstet Gynecol Scand65,195–198.
Ubaldi F , Bourgain C, Tournaye H, Smitz J, Van Steirteghem A and Devroey P (1997) Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril67,521–526.